Outsourcing global clinical

& medical engagement for accelerated drug approval

& acceptance
Flexible, scalable sales teams for rapid product launch

& lifecycle management
Real-time insights
powered by a one-of-a-kind comprehensive qualitative database — AnswerY

Premium content & audience access to critical oncology care networks

Continuous growth for teams and individuals led by pharma industry experts

Infectious Disease Oncology

Uncovers The “Why” Behind Prescriber Decisions

Download PDF
AnswerY helps client understand nuances behind HCP treatment rationale, boost their research capabilities + inform strategic initiatives for smarter next steps.
Download PDF
The Ask
CLIENT
Global
Large BioPharma
AnswerY helps fill data gaps to answer the why behind treatment decisions.
Expand Data Gaps
Fill RWE knowledge gaps + enhance their NLP + ML models for deeper, more holistic insights.
Need Nuanced, Behind-The-Scenes Intel
Want a compliant, qualitative dataset that provides real insights into prescriber treatment rationale.
The Approach
TOOLS
AnswerY
Data Scientists
The AnswerY platform empowers your data scientists to query data.
Double Down On Unique Data
Request additional HIPAA-compliant HCP patient notes after realizing value in raw oncology record samples.
Ongoing Education & Support
Conduct learning sessions and provide access to HIPAA-compliant database + platform, enabling their data scientists to query data + consult our experts.
Regularly Updated Data
Receive monthly data refreshes + send to internal data lake to maintain quality + integrity and ensure secure + easy access.
The Results
OUTCOME
Cost-Effective Research
Richer Insights
Client Satisfaction
AnswerY supports organization-wide market research and patient identification.
Confirmed Tier 1 Status
Designated AnswerY as Tier 1, providing organization-wide access to support strategy development, competitive analysis, market research, and patient identification.
Context Revealed The "Why"
Access to prescriber-patient interactions helped brand leaders understand treatment responses + the impact of social health determinants.
Cost + Time Savings
Served as compliant + valuable supplement to existing studies versus costly + resource-heavy market research.
Extended Data Partnership
Renewed AnswerY enterprise license 3 times to date.

Read Next

Read More arrow
Read More arrow
Read More arrow